PER 0.00% 10.0¢ percheron therapeutics limited

Ann: Positive feedback received on Paediatric Investigation Plan, page-93

  1. 478 Posts.
    lightbulb Created with Sketch. 58
    There are known knowns and known unknowns. There are also unknown unknowns which makes it all the more difficult.
    It looks like the stuff works in DMD nonambulant but there are many competing technologies after the same pot of gold including gene therapies which have the potential to cure the condition.
    In spite of the unknowns the current knowns look very favourable to me hence recent top ups.
    DYOR
    GLLTH.
    Cheers QS
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.